ID
21014
Beschrijving
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one. Source & Descriptions: https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Link
https://clinicaltrials.gov/ct2/show/NCT00153062?term=NCT00153062&rank=1
Trefwoorden
Versies (2)
- 22-02-17 22-02-17 -
- 03-04-17 03-04-17 -
Geüploaded op
3 april 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Death Report Form PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Death Report Form PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Beschrijving
Please remember to fax Supporting Documentation clearly identified with the patient number
Beschrijving
Invenstigator´s Declaration
Alias
- UMLS CUI-1
- C0008961
Beschrijving
Invenstigator´s Declaration
Datatype
text
Beschrijving
Investigator´s signature
Datatype
text
Alias
- UMLS CUI [1]
- C2346576
Beschrijving
Date of Signature
Datatype
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1519316
Similar models
Death Report Form PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
C0457432 (UMLS CUI [1,2])
C2348235 (UMLS CUI [1,2])
C1519316 (UMLS CUI [1,2])